FDA Drug Recalls

Recalls / Class II

Class IID-0609-2020

Product

Fluphenazine Decanoate Injection USP 125mg/5mL, (5 mL Multiple Dose Vial), Rx only, For IM or SC Use, Mfd in India for: AuroMedics Pharma, LLC, E. Windsor, NJ

Affected lot / code info
Lot CFD190004, exp. date August 2020

Why it was recalled

Discoloration; Hazy solution found in one vial instead of a clear solution.

Recalling firm

Firm
AuroMedics Pharma LLC
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
279 Princeton Hightstown Rd, East Windsor, New Jersey 08520-1401

Distribution

Quantity
59,500 vials
Distribution pattern
Product was distributed to major wholesalers/distributors who may have further distribute the product throughout the United States.

Timeline

Recall initiated
2019-11-12
FDA classified
2019-12-09
Posted by FDA
2019-12-11
Terminated
2021-01-21
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0609-2020. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls